FDA – Desenvolvimento de produtos biossimilares e biossimilares intercambiáveis.
FDA – Perguntas & Respostas – Dezembro/2018 Desenvolvimento de produtos biossimilares e biossimilares intercambiáveis. This guidance document provides answers to common questions from prospective applicants and other interested parties regarding the Biologics Price Competition and Innovation Act of 2009 (BPCI Act). The question and answer (Q&A) format is intended to inform prospective applicants and facilitate […]